![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 1423-0313|93|1-2|76-83
ISSN: 0031-7012
Source: Pharmacology, Vol.93, Iss.1-2, 2014-02, pp. : 76-83
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/o.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The CYP2C19 Enzyme Polymorphism
Pharmacology, Vol. 61, Iss. 3, 2000-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Inhibitory Effect of Apigenin on Losartan Metabolism and CYP2C9 Activity in vitro
Pharmacology, Vol. 98, Iss. 3-4, 2016-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Effects of CYP2C19 Variants on Fluoxetine Metabolism in vitro
Pharmacology, Vol. 100, Iss. 1-2, 2017-05 ,pp. :